The Rosen Law Firm, a global investor rights law firm, is urging investors who purchased common stock of Medpace Holdings, Inc. (NASDAQ:MEDP) between April 22, 2025, and February 9, 2026, to take action before the June 8, 2026, deadline to join a securities class action lawsuit. The lawsuit alleges that Medpace's management made misleading statements regarding the company's backlog cancellation rates, which led to inflated growth expectations that could not be sustained. Investors may be entitled to compensation without incurring any upfront costs through a contingency fee arrangement. To join the class action, investors can visit the Rosen Law Firm's website or contact them directly. The firm emphasizes the importance of selecting experienced legal counsel, as many firms may lack the necessary expertise in litigating securities class actions. The Rosen Law Firm has a proven track record, including the largest securities class action settlement against a Chinese company and consistently ranking among the top firms for securities class action settlements. As of now, no class has been certified, meaning that investors must retain counsel to be represented in the lawsuit.